Literature DB >> 17239465

Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.

Ken-ichi Abe1, Masanori Ikeda, Hiromichi Dansako, Kazuhito Naka, Nobuyuki Kato.   

Abstract

We recently established a genome-length HCV RNA-replicating cell line (O strain of genotype 1b; here called O cells) using cured cells derived from sO cells, in which HCV subgenomic replicon RNA with an adaptive NS5A mutation (S2200R) is replicated. Characterization of the O cells revealed a second adaptive NS3 mutation (K1609E) required for genome-length HCV RNA replication. To clarify the role of adaptive mutation in genome-length HCV RNA replication, we newly established one and three kinds of genome-length HCV RNA-replicating cell lines possessing the cell background of sO and O cells, respectively, and found additional adaptive NS3 mutations (Q1112R, P1115L, and E1202G) required for the robust replication of genome-length HCV RNA. We further found that specific combinations of adaptive NS3 mutations drastically enhanced HCV RNA replication, regardless of the cell lines examined. These findings suggest that specific viral factors may affect the replication level of genome-length HCV RNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17239465     DOI: 10.1016/j.virusres.2006.12.011

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

1.  Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities.

Authors:  Weilin Gu; Youki Ueda; Hiromichi Dansako; Shinya Satoh; Nobuyuki Kato
Journal:  FASEB Bioadv       Date:  2021-03-04

2.  New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication.

Authors:  Youki Ueda; Midori Takeda; Kyoko Mori; Hiromichi Dansako; Takaji Wakita; Hye-Sook Kim; Akira Sato; Yusuke Wataya; Masanori Ikeda; Nobuyuki Kato
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

3.  Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture.

Authors:  Erica Silberstein; Deborah R Taylor
Journal:  Int J Biomed Sci       Date:  2008-06

Review 4.  Modulation of host metabolism as a target of new antivirals.

Authors:  Masanori Ikeda; Nobuyuki Kato
Journal:  Adv Drug Deliv Rev       Date:  2007-08-11       Impact factor: 15.470

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.